Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2020Frontiers in PharmacologyOpen Access

Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion

View Full Paper
Ask AI
Bookmark
Share

Authors

LDLiancheng DengWenzhou Medical UniversityTATahereh AlinejadWenzhou Medical UniversitySBSavério BellusciJustus-Liebig-Universität Gießen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Deng et al. (2020) studied this question.

synapsesocial.com/papers/6a91b47b2c9f827804a7ff3chttps://doi.org/10.3389/fphar.2020.00426
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regulation of Fibroblast Growth Factor-23 Signaling by Klotho2006 · 1,377 citations
  2. 2Neuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-κB-dependent neuroinflammation and activating PI3K/Akt survival signaling pathway in mice2016 · 77 citations
  3. 3Induction of FGF-7 after kidney damage: a possible paracrine mechanism for tubule repair1996 · 52 citations
  4. 4Mechanisms and therapeutic targets of ischemic acute kidney injury2019 · 268 citations
  5. 5Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction2013 · 14 citations